S07 E02: VML’s Nichole Davies on the good, the bad and the ugly in women’s health
EMJ GOLD: Pharma marketing, medical & more
Release Date: 06/11/2024
S09 E06: Boston Scientific’s Angelo Auricchio on what’s next for heart health
EMJ GOLD: Pharma marketing, medical & more
This week, join Isabel and Jade as they explore what’s on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific. He and Isabel discuss Angelo’s recent career change into the industry, how technology could reform the UK’s NHS, the role of remote monitoring in patient wellbeing and more. A little more on EMJ GOLD’s guest… Angelo Auricchio was appointed Chief Medical Officer, Rhythm Management, Boston Scientific in September 2024, where he works across the...
info_outline
S09 E05: The HBA’s Mary Stutts on tackling bias for better women’s health
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade as they explore the persistent misunderstandings of women’s health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen’s Association. In this episode, Mary unpacks the key findings of the HBA’s latest report, which exposes critical gaps in doctors’ understanding of women’s health. She discusses the root causes, the real-world consequences and what the pharmaceutical industry must do to drive meaningful change. A little more on EMJ GOLD’s guest… Mary is the CEO of the HBA, a global organisation with a mission is...
info_outline
S09 E04: Does interactivity boost memory, recall and retention?
EMJ GOLD: Pharma marketing, medical & more
Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies and ultimately improves patient care. Read our article exploring the topic further . And if you’re interested to see how interactive works in the medical context, check out the interactive article mentioned .
info_outline
S09 E03: J&J’s Martin Price on World Cancer Day 2025 – Part 2
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space. In this instalment, Martin shares his thoughts on improving access to innovative cancer medicines, improving public trust toward the industry and his personal leadership style. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in Europe, the Middle East and...
info_outline
S09 E02: J&J's Martin Price on World Cancer Day
EMJ GOLD: Pharma marketing, medical & more
Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this year’s theme ‘United by Unique’, the increasing importance of real-world evidence in oncology and improving access to innovative cancer medicines. A little more on GOLD’s guest… Martin Price is Vice President for Health Economics, Market Access and Reimbursement in...
info_outline
S09 E01: Lundbeck’s Charl van Zyl on a new era in neurology
EMJ GOLD: Pharma marketing, medical & more
The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are welcomed by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more to support patients living brain conditions. Together, Charl and Isabel explore his career journey in the pharmaceutical industry, Lundbeck’s plans for the future, the role of digital health technology and much more. A little more on EMJ GOLD’s guest... Charl van Zyl...
info_outline
The 2025 pharma forecast
EMJ GOLD: Pharma marketing, medical & more
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise. A little more on GOLD’s guests… Jennifer Schranz is the Senior Vice President, Global Head of Rare...
info_outline
Bonus episode: Pharma review of the year 2024
EMJ GOLD: Pharma marketing, medical & more
As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024, including advancements in oncology, gene therapy, rare diseases and the growing role of AI. A...
info_outline
S08 E10: Bayer’s Dr Cecilia Caetano on making space for menopause
EMJ GOLD: Pharma marketing, medical & more
In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women’s Health, Bayer. Menopause affects over 50% of the world’s population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but also women with the knowledge and awareness to manage menopause on an individual level, debunking the myths and prejudices surrounding the topic and much more.
info_outline
Season 8 highlights: GOLD Medal Moments
EMJ GOLD: Pharma marketing, medical & more
Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there’s plenty to discover in this season’s GOLD Medal Moments.
info_outlineWith Season 7 in full swing, Isabel dives deep into the fascinating world of women’s health with Nichole Davies, Chief Strategy Officer, VML, to uncover the truth behind why women live longer but in poorer health and how the industry can incite change.
In the interview, they discuss the rise of FemTech, the challenge of funding and reimbursement, the role men can play in moving the conversation up the agenda and more.
A little more on GOLD’s guest…
Nichole leads the strategic disciplines and teams for the global VML Health network, overseeing research and development for all client and agency strategy and messaging. With over 20 years in the healthcare industry, she has worked in cities including London, New York, San Francisco, and Singapore. Nichole previously led strategy for Wunderman Thompson Health, Grey Health and Interbrand Health, following a decade in consulting.
Her experience covers diverse areas such as oncology, immunology, rare diseases, respiratory health, women's health, diabetes and nutrition. Nichole has collaborated with industry leaders like AstraZeneca, Pfizer and Johnson & Johnson.
Nichole graduated with honors in Chemistry from UMIST and completed her Postgrad in Marketing at London Business School. A Chartered Marketer, she is dedicated to driving change for improved patient outcomes and has worked with the Department of Health on patient communication standards.